Matches in Wikidata for { <http://www.wikidata.org/entity/Q63402977> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q63402977 description "assaig clínic" @default.
- Q63402977 description "clinical trial" @default.
- Q63402977 description "clinical trial" @default.
- Q63402977 description "clinical trial" @default.
- Q63402977 description "clinical trial" @default.
- Q63402977 description "ensaio clínico" @default.
- Q63402977 description "ensayo clínico" @default.
- Q63402977 description "ensayu clínicu" @default.
- Q63402977 description "essai clinique" @default.
- Q63402977 description "klinisch onderzoek" @default.
- Q63402977 description "клінічне випробування" @default.
- Q63402977 name "A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)" @default.
- Q63402977 type Item @default.
- Q63402977 label "A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)" @default.
- Q63402977 prefLabel "A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)" @default.
- Q63402977 P1050 Q63402977-2800AA74-7D65-410E-926C-0D6B0A80B6CC @default.
- Q63402977 P1132 Q63402977-F2207A8F-D895-4766-8B94-624B6F821B79 @default.
- Q63402977 P1476 Q63402977-74A7C482-D119-49FA-AB08-0B52AAFE9B77 @default.
- Q63402977 P17 Q63402977-7D20F894-D6EC-4D31-B0A0-3FB0B59622E5 @default.
- Q63402977 P1813 Q63402977-4C3E96B1-CA5B-4724-85CF-2559D0CB75AE @default.
- Q63402977 P2899 Q63402977-35255D9E-F029-40AF-8AEE-39348268D487 @default.
- Q63402977 P3098 Q63402977-C9F22922-ADAA-4D9E-8112-0F4591CD0C71 @default.
- Q63402977 P31 Q63402977-81182366-AA96-4692-A435-A488A56DEAF2 @default.
- Q63402977 P580 Q63402977-39C50D5C-F7F5-4291-BE0A-5A7E1DD33DAD @default.
- Q63402977 P582 Q63402977-C9BA5EE4-7D4E-4993-9BFC-BD2B9A70503B @default.
- Q63402977 P6099 Q63402977-AC855C4A-6CD2-4A70-8426-23F1E6B0C561 @default.
- Q63402977 P8363 Q63402977-2474C5F8-B63E-4122-B90F-66778DB3268B @default.
- Q63402977 P1050 Q1467339 @default.
- Q63402977 P1132 "+245" @default.
- Q63402977 P1476 "A Phase 3, Multi-center, Placebo-controlled, Randomized, Double-blind 26-week Study to Assess the Safety and Efficacy of CaPre® in Patients With Severe Hypertriglyceridemia." @default.
- Q63402977 P17 Q30 @default.
- Q63402977 P1813 "TRILOGY 1" @default.
- Q63402977 P2899 "+18" @default.
- Q63402977 P3098 "NCT03398005" @default.
- Q63402977 P31 Q30612 @default.
- Q63402977 P580 "2018-01-23T00:00:00Z" @default.
- Q63402977 P582 "2019-04-01T00:00:00Z" @default.
- Q63402977 P6099 Q42824827 @default.
- Q63402977 P8363 Q78089383 @default.